Nutex Health Inc.

Nutex Health Inc.

NUTXNYSE / NASDAQHealthcareSmall cap

$162.64+$0.54 (+0.3%)

Last close · Data as of Nov 20, 2026

Market cap
$929.7M
P/E
13.1x
EV / EBITDA
3.8x
Revenue
$875.3M
Net margin
8.1%
ROCE
71.6%

+14.3% over the last year

Nutex Health Inc. price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
-18.3%
3M
-13.7%
6M
+33.8%
1Y
+14.3%
5Y
Short history
  • A period is left blank when the price history is shorter than the period.

52-week range

Day change +$0.54 (+0.3%) from $162 to $163 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in NUTX, bought on each weekday since 2022.

News & filings

What Nutex Health filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

ConcernReturn on equity fell from 39.3% to 21.5% between fiscal 2024 and fiscal 2025.

Strengths (1)

  • Return on capital employed of 71.6%.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate.

Read moreShow less

Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatient pharmacies. The PHM segment provides management, administrative, and other support services to its affiliated hospitals and physician groups by establishing and operating provider networks, such as independent physician associations (IPAs); and a cloud-based technology platform for IPAs. The Real Estate segment owns and leases land and hospital buildings. Nutex Health Inc. was founded in 2011 and is headquartered in Houston, Texas.

Sector
Healthcare
Shares outstanding
7.1M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$929.7M
P/E
13.1x
P/B
2.8x
EV / EBITDA
3.8x
EV / Sales
1.3x
P/S
1.1x
52-week high
$225.00
52-week low
$87.01

Profitability

Operating margin
31.5%
Net margin
8.1%
EBITDA margin
32.9%
ROE
21.5%
ROCE
71.6%
ROIC
33.4%
ROA
7.7%
Asset turnover
0.95

Growth

Revenue
$875.3M
Revenue growth, 1Y
82.4%
Revenue CAGR, 3Y
58.6%
Net profit growth, 1Y
35.9%
Free cash flow
$245.6M

Solvency

Current ratio
3.41
Debt / Equity
1.07
Debt / Assets
0.38
CFO / Net profit
3.51
Cash / Market cap
20.0%

Where the revenue went

Of every $100 of FY2025 revenue, $8 was left as net income.

Nutex Health Inc. income statement flow, FY2025
Nutex Health Inc. income statement flow, FY2025: flows
FromToAmount
RevenueCost of revenue$431.0M
RevenueGross profit$444.3M
Gross profitOperating expenses$168.7M
Gross profitOperating income$275.6M
Operating incomePretax income$244.8M
Operating incomeInterest and other expense$30.8M
Pretax incomeTax and other$174.0M
Pretax incomeNet income$70.8M

Revenue and net profit

Revenue grew 82.4% in FY2025; net profit is the dashed line.

Nutex Health Inc. revenue and net profit by fiscal year
Nutex Health Inc. revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$219.3M-$424.8M
FY2023$247.6M-$45.8M
FY2024$479.9M$52.1M
FY2025$875.3M$70.8M

Cash flows

FY2025: $248.1M from operations, $245.6M free after investment (dashed).

Nutex Health Inc. operating and free cash flow by fiscal year
Nutex Health Inc. operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$50.6M$36.0M
FY2023$1.3M-$8.2M
FY2024$23.2M$20.8M
FY2025$248.1M$245.6M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$875.3M+82.4%1Y
EBITDA
$287.5M+93.3%1Y
Net profit
$70.8M+35.9%1Y
Cash from operations
$248.1M+971.7%1Y
Free cash flow
$245.6M+1,078.0%1Y
Revenue CAGR, 3Y
58.6%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$875.3M$287.5M$70.8M$245.6M21.5%+82.4%+35.9%

Monthly returns

Month-by-month returns of NUTX across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$918.5M
Liabilities$495.1M
Equity$423.4M
Paid-in capital$615.6M
Retained earnings-$286.2M
Minority interest$94.0M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; NUTX highlighted.

P/E against peers

NUTX trades at 13.1x earnings against a peer median of -4.2x.

  1. Nutex Health Inc. (this company)13.1x

EV / Sales, for the companies without earnings

Not shown (no positive earnings and no EV / Sales): Olema Pharmaceuticals, Inc., Annexon, Inc., Cullinan Therapeutics, Inc.

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
Nutex Health Inc.NUTXthis company$929.7M13.1x2.8x21.5%3.8x
U.S. Physical Therapy, Inc.USPH$940.1M62.4x2.0x3.2%11.1x
Anteris Technologies Global Corp.AVR$939.4M—48.7x-238.4%—
Olema Pharmaceuticals, Inc.OLMA$932.9M-5.7x1.9x-33.9%-5.0x
ARS Pharmaceuticals, Inc.SPRY$900.7M-5.3x7.9x-149.9%-5.7x
Annexon, Inc.ANNX$892.9M-4.3x4.2x-97.7%-3.5x
Pacira BioSciences, Inc.PCRX$892.0M126.9x1.3x1.0%8.7x
Xencor, Inc.XNCR$890.4M—1.4x-14.5%—
Cullinan Therapeutics, Inc.CGEM$886.8M-4.0x2.2x-53.8%-3.3x
Peer median—-4.2x2.1x-43.9%-3.4x

Year-to-date ROI

NUTX since 1 January, against earlier years.

Historical volatility

NUTX's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

Nutex Health Inc. operating margin by fiscal year
Nutex Health Inc. operating margin by fiscal year
DateOperating margin
FY2022-2.1%
FY2023-0.6%
FY202428.7%
FY202531.5%
LineFY2025
Cost of revenueCost Of Revenue$431.0M
Gross profitGross Profit$444.3M
Operating expensesOperating Expense$168.7M
Other operating expensesOther Operating Expenses—
Total expensesTotal Expenses$599.6M
Pretax incomePretax Income$244.8M

Learn while you research

Academy chapters picked for Nutex Health Inc. and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Growth Investing82% revenue growth is in the top tier, learn how to value growth.7 min read
  3. 03 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
  4. 04 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  5. 05 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  6. 06 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →